Methyldopa
3 NDCs across 2 manufacturers|3 Generic,0 Brand
Methyldopa is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Apr 18, 1985.
Methyldopa is available as 3 NDCs from 2 manufacturers (3 generic, 0 brand), with NADAC prices from $7.50 to $7.50 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
2
competing in market
Price Spread
$7.50 – $7.50
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing METHYLDOPA
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
METHYLDOPA 250 MG TABLET | $7.4999 per EA | — |
METHYLDOPA 250 MG TABLET | $7.4999 per EA | — |
METHYLDOPA 250 MG TABLET | $7.4999 per EA | — |
Frequently Asked Questions
What is Methyldopa used to treat?
Methyldopa is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
When did Methyldopa become available as a generic?
FDA approved the first generic Methyldopa (ANDA) on Apr 18, 1985.
How many Methyldopa products are on the market?
The Methyldopa drug market contains 3 NDCs from 2 manufacturers — 3 generic and 0 brand products.
What is the price range for Methyldopa?
NADAC reference prices for Methyldopa range from $7.4999 to $7.4999 per EA.
Which manufacturers make Methyldopa?
2 manufacturers list Methyldopa in NADAC. Ranked by number of NDCs, the largest are Chartwell RX LLC (2), Rising Pharma Holdings Inc. (1).